| __timestamp | Soleno Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 5496000 |
| Thursday, January 1, 2015 | 7878291 | 9786000 |
| Friday, January 1, 2016 | 8366794 | 6792000 |
| Sunday, January 1, 2017 | 6610381 | 7313000 |
| Monday, January 1, 2018 | 6556000 | 8382000 |
| Tuesday, January 1, 2019 | 6930000 | 10803000 |
| Wednesday, January 1, 2020 | 8758000 | 12944000 |
| Friday, January 1, 2021 | 10806000 | 21967000 |
| Saturday, January 1, 2022 | 9844000 | 32810000 |
| Sunday, January 1, 2023 | 13481000 | 46542000 |
Cracking the code
In the competitive world of biotechnology, managing expenses is crucial for success. This analysis of SG&A (Selling, General, and Administrative) expenses from 2014 to 2023 reveals intriguing trends for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc. Over this period, Xenon Pharmaceuticals has consistently outpaced Soleno Therapeutics, with a remarkable 750% increase in SG&A expenses, peaking at $46.5 million in 2023. In contrast, Soleno Therapeutics saw a more modest 360% rise, reaching $13.5 million in the same year. This disparity highlights Xenon's aggressive growth strategy, possibly reflecting its investment in expanding operations and market reach. Meanwhile, Soleno's steadier increase suggests a more conservative approach. These trends offer valuable insights into the strategic priorities of these companies, providing investors and industry analysts with a clearer picture of their financial trajectories.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared